ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluating the Safety and Immune Response of a Prime-Boost HIV Vaccine Regimen in Healthy, HIV-Uninfected, Vaccinia-Naive Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01571960
Recruitment Status : Completed
First Posted : April 5, 2012
Last Update Posted : January 24, 2017
Sponsor:
Collaborator:
GeoVax, Inc.
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2014
  Actual Study Completion Date : January 2016
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):